ArticleDusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi2024
Comparison of greater occipital and supraorbital nerve block with amitriptyline use in migraine treatment.
Article in Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Migraine, a condition requiring long-term preventive therapy, especially for individuals with frequent and severe attacks. This study aims to compare the effectiveness of GON and SON (Greater Occipital Nerve and Supraorbital Nerve) blockades with amitriptyline in migraine management. Method: This retrospective study included 57 patients diagnosed with migraines. The first group consisted of patients who received a daily dose of 25 mg of amitriptyline for six months. The second group consisted of patients who initially received bilateral GON and SON blockades administered weekly for one month, followed by monthly blockade treatments for a total of 5 months. Pain frequency, analgesic consumption, and VAS (Visual Analog Scale) scores recorded in patients' follow-up files were compared between the groups before treatment and at the 1 Results: Records of 57 patients, comprising 5 males and 52 females, were examined. Among them, 25 received GON and SON blockades, while 32 were treated with amitriptyline. Both groups showed a decrease in pain frequency and fewer painful days over time, with significant differences observed at all time points compared to baseline and between the 1 Conclusion: This study suggests that GON and SON blockades could be an effective prophylactic treatment for migraines, highlighting its potential as an alternative to amitriptyline therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.